Besides the oncogenic role of DDX3 in cancer biogenesis, there is a report that indicates loss of DDX3 via p53 inactivation can promote tumor malignancy in non-small cell lung cancer (Wu et al, 2014). Here, DDX3X is linked to non-small cell lung carcinoma.